New classification: leukaemia subtypes reveal potential of existing drugs
Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present…
Browsing: AML
New maintenance treatment for acute myeloid leukaemia prolongs the lives of patients
Patients with acute myeloid leukaemia (AML), the most common form of acute leukaemia in adults,…
Palliative care improves quality of life for patients with advanced blood cancer
A first-of-its-kind intervention integrating palliative care early in the course of cancer therapy for patients…
Global trial reveals life saving drug for acute myeloid leukaemia
A landmark paper published today in the New England Journal of Medicine describes the results from a…
Baking soda treatment may help prevent leukaemia relapse after stem cell transplants
Scientists have discovered that sodium bicarbonate – also known as baking soda or bicarbonate of…
Why do certain chemotherapies increase the likelihood of blood cancer?
In recent years, improvements in cancer therapy have led to a significant increase in cancer…
Combination therapy improves survival outcomes for patients with acute myeloid leukaemia
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over…
A new nanoconjugate blocks acute myeloid leukaemia tumour cells without harming healthy ones
Acute myeloid leukaemia (AML) is a heterogeneous disease which usual treatment is very aggressive and…
Blood cancer find raises new treatment hopes
New QIMR Berghofer research has identified how an early genetic change in blood and bone…
EHA 2020: A paradigm shift for the treatment of newly diagnosed older acute myeloid leukaemia patients
Acute myeloid leukaemia (AML) is primarily a disease of older adults. Standard commonly utilised lower-intensity…